Previous studies have shown that GSK-3β overexpression plays key roles in multiple types of cancer, including ovarian cancer [22], breast cancer [23], pancreatic cancer [24–26], colon cancer [27], bladder cancer [28], myeloma [29] and leukaemia [30]. This evidence concerns the gene GSK3B and familial pancreatic carcinoma.